Cell Biology International,
Journal Year:
2021,
Volume and Issue:
45(9), P. 1807 - 1831
Published: April 29, 2021
Exosomes
are
nano-sized
bioactive
vesicles
of
30-150
nm
in
diameter.
They
secreted
by
exocytosis
nearly
all
type
cells
to
the
extracellular
fluid.
Thereby,
they
can
be
found
many
biological
fluids.
regulate
intracellular
communication
between
via
delivery
their
cargo
which
include
lipids,
proteins,
and
nucleic
acid.
Many
desirable
features
exosomes
made
them
promising
candidates
several
therapeutic
applications.
In
this
review,
we
discuss
use
as
diagnostic
tools
possible
biomedical
Additionally,
current
techniques
used
for
isolation,
purification,
characterization
from
both
fluids
vitro
cell
cultures
were
discussed.
International Journal of Nanomedicine,
Journal Year:
2020,
Volume and Issue:
Volume 15, P. 6917 - 6934
Published: Sept. 1, 2020
Exosomes
are
nano-sized
small
extracellular
vesicles
secreted
by
cells,
carrying
nucleic
acids,
proteins,
lipids
and
other
bioactive
substances
to
play
a
role
in
the
body's
physiological
pathological
processes.
Compared
synthetic
carriers
such
as
liposomes
nanoparticles,
endogeneity
heterogeneity
of
exosomes
give
them
extensive
unique
advantages
field
disease
diagnosis
treatment.
However,
storage
stability,
low
yield,
purity,
weak
targeting
limit
its
clinical
application.
For
this
reason,
further
exploration
is
needed
optimize
above
problems
facilitate
future
functional
studies
exosomes.
In
paper,
origin,
classification,
preparation
characterization,
stability
applications
exosome
delivery
system
summarized
discussed
searching
large
number
literatures.
Journal of Hematology & Oncology,
Journal Year:
2020,
Volume and Issue:
13(1)
Published: Nov. 10, 2020
Abstract
Exosomes
are
a
subset
of
extracellular
vesicles
that
carry
specific
combinations
proteins,
nucleic
acids,
metabolites,
and
lipids.
Mounting
evidence
suggests
exosomes
participate
in
intercellular
communication
act
as
important
molecular
vehicles
the
regulation
numerous
physiological
pathological
processes,
including
cancer
development.
released
by
various
cell
types
under
both
normal
conditions,
they
can
be
found
multiple
bodily
fluids.
Moreover,
carrying
wide
variety
macromolecules
provide
window
into
altered
cellular
or
tissue
states.
Their
presence
biological
fluids
renders
them
an
attractive,
minimally
invasive
approach
for
liquid
biopsies
with
potential
biomarkers
diagnosis,
prediction,
surveillance.
Due
to
their
biocompatibility
low
immunogenicity
cytotoxicity,
have
clinical
applications
development
innovative
therapeutic
approaches.
Here,
we
summarize
recent
advances
technologies
exosome
isolation
research.
We
outline
functions
regulating
tumor
metastasis,
drug
resistance,
immune
modulation
context
Finally,
discuss
prospects
challenges
exosome-based
therapeutics.
Journal of Nanobiotechnology,
Journal Year:
2021,
Volume and Issue:
19(1)
Published: Aug. 12, 2021
Abstract
Exosomes
are
lipid
bilayer
membrane
vesicles
and
emerging
as
competent
nanocarriers
for
drug
delivery.
The
clinical
translation
of
exosomes
faces
many
challenges
such
massive
production,
standard
isolation,
loading,
stability
quality
control.
In
recent
years,
artificial
based
on
nanobiotechnology
to
overcome
the
limitations
natural
exosomes.
Major
types
include
‘nanovesicles
(NVs)’,
‘exosome-mimetic
(EM)’
‘hybrid
(HEs)’,
which
obtained
by
top-down,
bottom-up
biohybrid
strategies,
respectively.
Artificial
powerful
alternatives
Here,
we
outline
advances
in
through
discuss
their
strengths,
future
perspectives.
development
holds
great
values
translational
nanomedicine.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Jan. 12, 2024
Abstract
Although
stem
cell-based
therapy
has
demonstrated
considerable
potential
to
manage
certain
diseases
more
successfully
than
conventional
surgery,
it
nevertheless
comes
with
inescapable
drawbacks
that
might
limit
its
clinical
translation.
Compared
cells,
cell-derived
exosomes
possess
numerous
advantages,
such
as
non-immunogenicity,
non-infusion
toxicity,
easy
access,
effortless
preservation,
and
freedom
from
tumorigenic
ethical
issues.
Exosomes
can
inherit
similar
therapeutic
effects
their
parental
cells
embryonic
adult
through
vertical
delivery
of
pluripotency
or
multipotency.
After
a
thorough
search
meticulous
dissection
relevant
literature
the
last
five
years,
we
present
this
comprehensive,
up-to-date,
specialty-specific
disease-oriented
review
highlight
surgical
application
exosomes.
derived
(e.g.,
embryonic,
induced
pluripotent,
hematopoietic,
mesenchymal,
neural,
endothelial
cells)
are
capable
treating
encountered
in
orthopedic
neurosurgery,
plastic
general
cardiothoracic
urology,
head
neck
ophthalmology,
obstetrics
gynecology.
The
diverse
cells-derived
hierarchical
translation
tissue-specific
responses,
cell-specific
molecular
signaling
pathways.
In
review,
viable
potent
alternative
managing
various
conditions.
We
recommend
future
research
combines
wisdoms
surgeons,
nanomedicine
practitioners,
cell
researchers
intriguing
area.
Theranostics,
Journal Year:
2020,
Volume and Issue:
10(13), P. 5979 - 5997
Published: Jan. 1, 2020
Mesenchymal
stem/stromal
cells
(MSCs)
are
important
players
in
tissue
homeostasis
and
regeneration
owing
to
their
immunomodulatory
potential
release
of
trophic
factors
that
promote
healing.They
have
been
increasingly
used
clinical
trials
treat
multiple
conditions
associated
with
inflammation
damage
such
as
graft
versus
host
disease,
orthopedic
injuries
cardiac
liver
diseases.Recent
evidence
demonstrates
beneficial
effects
derived,
at
least
part,
from
secretome.In
particular,
data
animal
models
first-in-man
studies
indicate
MSC-derived
extracellular
vesicles
(MSC-EVs)
can
exert
similar
therapeutic
origin.MSC-EVs
membranous
structures
loaded
proteins,
lipids,
carbohydrates
nucleic
acids,
which
play
an
role
cell-cell
communication
may
represent
attractive
alternative
for
cell-based
therapy.In
this
article
we
summarize
recent
advances
the
use
MSC-EVs
repair.We
highlight
several
isolation
characterization
approaches
enrich
EVs.We
discuss
our
current
understanding
relative
contribution
regenerative
mediated
by
MSCs
MSC
secretome.Finally
challenges
opportunities,
come
cell
free
therapy
require
repair.
Tzu Chi Medical Journal,
Journal Year:
2019,
Volume and Issue:
32(2), P. 113 - 113
Published: Dec. 5, 2019
Exosomes,
60-200-nm
extracellular
vesicles
secreted
from
cells,
have
been
used
as
an
active
pharmaceutical
ingredient
or
drug
carrier
in
disease
treatment.Human-and
plant-derived
exosomes
are
registered
clinical
trials,
but
more
complete
reports
available
for
human-derived
exosomes.Because
act
and
carry
cell
secreting
components,
they
peptide
vehicles
to
treat
diseases.The
dendritic
cells
(DCs)
mesenchymal
stem
(MSCs)
two
popular
sources
exosome
preparation.Exosomes
DCs
can
initiate
inflammation
patients,
particularly
patients
with
cancer,
contain
the
tumor
antigen
induce
specific
response.A
well-established
bank
of
MSCs
is
available,
these
be
alternative
source
preparation.The
major
application
MSC-derived
treatment.Exosomes
trials
need
comply
good
manufacturing
practice
(GMP).Three
important
issues
prevalent
GMP
exosomes,
i.e.,
upstream
cultivation
process,
downstream
purification
quality
control.This
paper
concisely
reviews
development,
including
generation
trial
application.
Journal of Clinical Medicine,
Journal Year:
2020,
Volume and Issue:
9(2), P. 436 - 436
Published: Feb. 6, 2020
Exosomes
are
a
heterogenous
subpopulation
of
extracellular
vesicles
30–150
nm
in
range
and
endosome-derived
origin.
We
explored
the
exosome
formation
through
different
systems,
including
endosomal
sorting
complex
required
for
transport
(ESCRT)
ESCRT-independent
system,
looking
at
mechanisms
release.
Different
isolation
techniques
specificities
exosomes
from
tissues
cells
also
discussed.
Despite
more
than
30
years
research
that
followed
their
definition
indicated
important
role
cellular
physiology,
biology
is
still
its
infancy
with
rapidly
growing
interest.
The
reasons
rapid
increase
interest
respect
to
because
they
provide
means
intercellular
communication
transmission
macromolecules
between
cells,
potential
development
diseases.
Moreover,
have
been
investigated
as
prognostic
biomarkers,
further
diagnostic
tools
neurodegenerative
diseases
cancer.
grows
fact
were
reported
useful
vectors
drugs.
Nanomaterials,
Journal Year:
2021,
Volume and Issue:
11(6), P. 1481 - 1481
Published: June 3, 2021
Exosomes
as
nanosized
vesicles
are
emerging
drug
delivery
systems
for
therapeutics
owing
to
their
natural
origin,
ability
mediate
intercellular
communication,
and
potential
encapsulate
various
biological
molecules
such
proteins
nucleic
acids
within
the
lipid
bilayer
membrane
or
in
lumen.
contain
endogenous
components
(proteins,
lipids,
RNA)
that
could
be
used
deliver
cargoes
target
cells,
offering
an
opportunity
diagnose
treat
diseases.
Owing
travel
safely
extracellular
fluid
transport
cells
with
high
efficacy,
exosomes
offer
enhanced
of
vivo.
However,
several
challenges
related
stabilization
exosomes,
production
sufficient
amounts
safety
efficient
loading
drugs
into
clearance
from
circulation,
transition
bench
scale
clinical
may
limit
development
use.
For
use
it
is
important
understand
molecular
mechanisms
behind
function
exosome
vesicles.
This
review
exploits
techniques
isolation
characterization
enhance
therapeutic
outcome
methods.
Further,
routes
administration,
trials,
regulatory
aspects
will
discussed
this
review.
Journal of Food Science,
Journal Year:
2021,
Volume and Issue:
86(7), P. 2838 - 2850
Published: June 20, 2021
Abstract
Plant‐derived
exosome‐like
nanoparticles
(PDENs)
are
small
vesicles
released
by
multivesicular
bodies
mainly
to
communicate
between
cells
and
regulate
immunity
against
pathogen
attack.
Current
studies
have
reported
that
PDENs
could
modulate
gene
expression
in
a
cross‐kingdom
fashion.
Therefore,
be
potential
future
functional
food
ingredient
as
their
communication
abilities
were
exert
multiple
health
benefits.
Macrophage
other
been
absorb
manner
regulated
the
membrane
lipid
protein
profile
intactness
of
bilayer.
extracted
from
plant
materials
various
techniques
such
ultracentrifugation,
immunoaffinity,
size‐based
isolation,
precipitation,
though
each
method
has
its
pros
cons.
contain
lipid,
protein,
genetic
materials,
micro
RNAs,
which
benefits
functionalities
when
consumed
sufficient
amounts.
However,
most
on
conducted
through
in‐vitro
in‐vivo
studies,
potency
used
remains
question
sensitive
storage
processing
condition
requires
costly
extraction
method.
This
concise
review
features
exosome
methods,
contents
roles,
PDENs,
ingredient.
Journal of Cellular and Molecular Medicine,
Journal Year:
2021,
Volume and Issue:
25(19), P. 9281 - 9294
Published: Aug. 27, 2021
Mesenchymal
stem
cells
(MSCs)
have
shown
chondroprotective
effects
in
clinical
models
of
osteoarthritis
(OA).
However,
MSC-derived
exosomes
on
OA
remain
unclear.
The
study
aimed
to
investigate
the
therapeutic
potential
from
human
bone
marrow
MSCs
(BM-MSCs)
alleviating
OA.
anterior
cruciate
ligament
transection
(ACLT)
and
destabilization
medial
meniscus
(DMM)
surgery
were
performed
knee
joints
a
rat
model,
followed
by
intra-articular
injection
BM-MSCs
or
their
exosomes.
In
addition,
BM-MSC-derived
administrated
primary
chondrocytes
observe
functional
molecular
alterations.
Both
alleviated
cartilage
destruction
subchondral
remodelling
model.
Administration
could
reduce
joint
damage
restore
trabecular
volume
fraction,
number
connectivity
density
rats.
vitro
assays
showed
that
BM-MSCs-exosomes
maintain
chondrocyte
phenotype
increasing
collagen
type
II
synthesis
inhibiting
IL-1β–induced
senescence
apoptosis.
Furthermore,
exosomal
lncRNA
MEG-3
also
reduced
apoptosis
induced
IL-1β,
indicating
might
partially
account
anti-OA
BM-MSC
exerted
beneficial
reducing
chondrocytes,
suggesting
provide
candidate
therapy
for
treatment.